North America Urinalysis Market

Market Introduction

The North America Urinalysis market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America Urinalysis market. The growth can be attributed to increase in the prevalence of chronic diseases, presence of key market players and extensive R&D conducted by various research laboratories and institutes. In addition, there is also a boom in public healthcare expenditure and an increase in the awareness programs that are further expected to stimulate the growth of the urinalysis market.

Lockdowns enacted by various North American countries to control the spread of COVID-19 caused people to delay undergoing health checkups, thus affecting the number of tests performed and sales of instruments, consumables, and reagents. However, a resurgence in testing numbers is seen as countries gradually ease the restrictions imposed on movement. According to National Kidney Foundation, people hospitalized with COVID-19 are at a significant risk of acute kidney injury (AKI), leading to serious illness, dialysis, and death. For the recovered COVID-19 patients who had an AKI or acute renal failure, urinalysis diagnosis is recommended since the risk of developing chronic kidney disease is higher in them than others. COVID-19 patients who did not develop an AKI, but had blood and/or protein in their urine, need to be monitored as they are at a greater risk of developing chronic- and end-stage kidney disease. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers are facing unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities. For instance, in August 2020, Sysmex America, Inc., a leading diagnostic solutions company, entered into a distribution agreement with Siemens Healthineers to increase the distribution of the CLINITEK Novus automated urine chemistry analyzer platform. Therefore, in the long run, upon the streamlining of the COVID-19 vaccination programs and the decrease in transmission rates, healthcare systems will return to normal and generate significant demand urinalysis products and services.      

Market Overview and Dynamics

The urinalysis market in North America is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The urinalysis market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launches, regional expansions, and technological advancements to expand their market share. Rising demand for rapid tests, point-of-care (PoC) testing, and portable instruments are encouraging new product launches in the urinalysis market. The PoC testing enables rapid results in non-laboratory settings, along with boosting productivity. These tests are cost-effective and encompass the diagnoses of a wide range of diseases. Moreover, the growing demand for PoC diagnostics products is further driving product innovations in the urinalysis market. Market players are readily investing in R&D to develop advanced technologies.   

Key Market Segments

North America urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the North America urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The North America urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the North America urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The North America urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the North America urinalysis market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the urinalysis market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.         

Reasons to buy report

• To understand the North America urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America urinalysis market.
• Efficiently plan M&A and partnership deals in North America urinalysis market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America urinalysis market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

North America Urinalysis Market Segmentation

North America Urinalysis Market - By Product

• Consumables
• Instruments

North America Urinalysis Market - By Test Type

• Pregnancy and Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

North America Urinalysis Market - By Application

• Disease Screening
• Pregnancy and Fertility

North America Urinalysis Market - By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories and Institutes

North America Urinalysis Market - By Country

• US
• Canada
• Mexico

North America Urinalysis Market - Company Profiles

• Abbott    
• ACON Laboratories, Inc.             
• ARKRAY, Inc.     
• Beckman Coulter, Inc.     
• Bio-Rad Laboratories Inc.            
• Cardinal Health Inc         
• F. Hoffmann-La Roche Ltd.          
• Quidel Corporation          
• Siemens Healthineers AG           
• Sysmex Corporation

North America Urinalysis Market Strategic Insights

North America UrinalysisMarket Report Highlights

North America Urinalysis Market Country and Regional Insights